<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
Creso Pharma Ltd (ASX:CPH, OTCQB:COPHF)’s Swiss operations have generated revenue of A$817,429 (CHF 552,548) in Q4 2021 – a 126% increase on the division’s revenue over last quarter of A$362,448. The strong figures are marked by the company’s strengthened partnership with Swiss-based Cannahealth AG, which is marketing and selling its products.
...read full article on Proactive Investors
